Dataset Information

The emerging roles of machine learning in cardiovascular diseases: a narrative review.

ABSTRACT:

Background and objective

With the wide application of electronic medical record systems in hospitals, massive medical data are available. This type of medical data has the characteristics of heterogeneity and multi-dimensionality. Traditional statistical methods cannot fully extract and use such data, but with their non-linear and cross-learning modes, machine-learning (ML) algorithms based on artificial intelligence can address these shortcomings. To explore the application of ML algorithms in the cardiovascular field, we retrieved and reviewed relevant articles published in the last 6 years and found that ML is practical and accurate in the auxiliary diagnosis of cardiovascular diseases. Thus, this article reviewed the research progress of ML in cardiovascular disease.

Methods

This study searched relevant literature published in National Center for Biotechnology Information (NCBI) PubMed from 2016 to 2022. The relevant literature was extracted from NCBI PubMed with the following keywords and their combinations: "machine learning", "artificial intelligence", "cardiology", "cardiovascular disease", "echocardiography", "electrocardiogram" and "prediction model". All articles included in the review are English.

Key content and findings

The review found that ML is practical and accurate in the diagnosis of cardiovascular diseases. Besides, ML can build clinical risk prediction models and help doctors evaluate the prognosis of patients.

Conclusions

The study summarized the progress of ML in cardiovascular diseases and confirmed its advantages in clinical application. In the future, models and software based on ML will be common auxiliary tools in clinical practice.

SUBMITTER: Chen L

PROVIDER: S-EPMC9201135 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The emerging roles of machine learning in cardiovascular diseases: a narrative review.

Chen Liang L Han Zhijun Z Wang Junhong J Yang Chengjian C

Annals of translational medicine 20220501 10

<h4>Background and objective</h4>With the wide application of electronic medical record systems in hospitals, massive medical data are available. This type of medical data has the characteristics of heterogeneity and multi-dimensionality. Traditional statistical methods cannot fully extract and use such data, but with their non-linear and cross-learning modes, machine-learning (ML) algorithms based on artificial intelligence can address these shortcomings. To explore the application of ML algori ...[more]

PMID: 35722382

Similar Datasets

Project description:The world has seen numerous infectious disease outbreaks in the past decade. In many cases these outbreaks have had considerable perinatal health consequences including increased risk of preterm delivery (e.g., influenza, measles, and COVID-19), and the delivery of low birth weight or small for gestational age babies (e.g., influenza, COVID-19). Furthermore, severe perinatal outcomes including perinatal and infant death are a known consequence of multiple infectious diseases (e.g., Ebola virus disease, Zika virus disease, pertussis, and measles). In addition to vaccination during pregnancy (where possible), pregnant women, are provided some level of protection from the adverse effects of infection through community-level application of evidence-based transmission-control methods. This review demonstrates that it takes almost 2 years for the perinatal impacts of an infectious disease outbreak to be reported. However, many infectious disease outbreaks between 2010 and 2020 have no associated pregnancy data reported in the scientific literature, or pregnancy data is reported in the form of case-studies only. This lack of systematic data collection and reporting has a negative impact on our understanding of these diseases and the implications they may have for pregnant women and their unborn infants. Monitoring perinatal health is an essential aspect of national and global healthcare strategies as perinatal life has a critical impact on early life mortality as well as possible effects on later life health. The unpredictable nature of emerging infections and the potential for adverse perinatal outcomes necessitate that we thoroughly assess pregnancy and perinatal health implications of disease outbreaks and their public health interventions in tandem with outbreak response efforts. Disease surveillance programs should incorporate perinatal health monitoring and health systems around the world should endeavor to continuously collect perinatal health data in order to quickly update pregnancy care protocols as needed.

Project description:ObjectiveTo summarize the roles of AKT-mTOR signaling in the regulation of the DNA damage response and PD-L1 expression in cancer cells, and propose a novel strategy of targeting AKT-mTOR signaling in combination with radioimmunotherapy in the era of cancer immunotherapy.BackgroundImmunotherapy has greatly improved the clinical outcomes of many cancer patients and has changed the landscape of cancer patient management. However, only a small subgroup of cancer patients (~20-30%) benefit from immune checkpoint blockade-based immunotherapy. The current challenge is to find biomarkers to predict the response of patients to immunotherapy and strategies to sensitize patients to immunotherapy.MethodsSearch and review the literature which were published in PUBMED from 2000-2021 with the key words mTOR, AKT, drug resistance, DNA damage response, immunotherapy, PD-L1, DNA repair, radioimmunotherapy.ConclusionsMore than 50% of cancer patients receive radiotherapy during their course of treatment. Radiotherapy has been shown to reduce the growth of locally irradiated tumors as well as metastatic non-irradiated tumors (abscopal effects) by affecting systemic immunity. Consistently, immunotherapy has been demonstrated to enhance radiotherapy with more than one hundred clinical trials of radiation in combination with immunotherapy (radioimmunotherapy) across cancer types. Nevertheless, current available data have shown limited efficacy of trials testing radioimmunotherapy. AKT-mTOR signaling is a major tumor growth-promoting pathway and is upregulated in most cancers. AKT-mTOR signaling is activated by growth factors as well as genotoxic stresses including radiotherapy. Importantly, recent advances have shown that AKT-mTOR is one of the main signaling pathways that regulate DNA damage repair as well as PD-L1 levels in cancers. These recent advances clearly suggest a novel cancer therapy strategy by targeting AKT-mTOR signaling in combination with radioimmunotherapy.

Dataset Information

The emerging roles of machine learning in cardiovascular diseases: a narrative review.

Background and objective

Methods

Key content and findings

Conclusions

Publications

The emerging roles of machine learning in cardiovascular diseases: a narrative review.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets